-

Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies

  • Majority-owned RI Research Instruments GmbH to supply Inner Vertical Targets (IVT) for ITER
  • BEST to supply novel high-current density RRP® superconductors for a tokamak fusion project in Asia

HANAU, Germany & BERGISCH GLADBACH, Germany & CARTERET, N.J.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced that its Bruker Energy & Supercon Technologies (BEST) division, and majority-owned RI Research Instruments GmbH (RI) have received multi-year contracts to supply key technology components for major fusion projects in Europe and Asia, together valued at approximately $50 million.

Though still in the research phase, magnetic confinement fusion holds promise as a clean, abundant, sustainable, efficient and safe energy source. Gigawatt fusion power may become a future key baseload technology to complement renewable, but inherently variable solar, wind and off-shore wind power, which all require very significantly more land-use.

Future fusion power plants could replace carbon dioxide-emitting fossil fuel plants, as well as nuclear fission reactors that generate long-lived radioactive waste. BEST and RI have a long history of providing advanced technologies to tokamak and stellerator magnetic confinement fusion projects. Many experts expect magnetic confinement fusion to lead to viable fusion power plants several decades before inertial confinement laser ignition may some day become useable for meaningful fusion power generation for the grid.

Following successful prototype demonstration, RI signed a multi-year contract for Inner Vertical Targets (IVTs) with Fusion for Energy (F4E), the EU organization responsible for Europe’s contribution to ITER - the biggest international experiment to test the potential of fusion energy through magnetic confinement. IVTs are modules of the 54 cassettes, and part of the ITER divertor, which is designed to withstand extreme plasma heat loads.

After many years of development of novel, high-current density, metallic RRP® (rod-restack process) superconductors for high-energy physics accelerator magnets, e.g. for the high-luminosity upgrade of the Large Hadron Collider (LHC) at CERN, and for use in high-field NMR magnets, BEST recently received a large order for these next-generation RRP superconductors for a new tokamak fusion project in Asia. Unlike high-temperature superconductor (HTS) YBCO tapes, robust RRP® wire can now be manufactured in large-scale, industrialized processes at volumes of thousands of kms at two advanced Bruker superconductor factories in the US and in Germany.

For more information on the ITER Diverter technology: https://fusionforenergy.europa.eu/news/europe-to-start-manufacturing-a-series-of-inner-vertical-targets/

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life-science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial research, semiconductor metrology and cleantech applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. Please visit www.bruker.com.

Contacts

Investor Relations
Justin Ward
Sr. Director Investor Relations & Corporate Development
T: +1 (978) 663–3660, ext. 1479
E: Investor.Relations@bruker.com

Bruker Corporation

NASDAQ:BRKR

Release Versions
$Cashtags
Hashtags

Contacts

Investor Relations
Justin Ward
Sr. Director Investor Relations & Corporate Development
T: +1 (978) 663–3660, ext. 1479
E: Investor.Relations@bruker.com

Social Media Profiles
More News From Bruker Corporation

RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)

BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of the Extreme Light Infrastructure – Nuclear Physics (ELI-NP) at the Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH) in Romania. The total value of these ELI contracts is approximately €35 million (more than USD $40 million), w...

Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions

ETTLINGEN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany: In the summer, École Normale Supérieure (ENS-PSL) in Paris, France ordered a novel NMR relaxometry system to be used alongside its recently acquired 900 MHz NMR spectrometer. This unique capability will empower the investigation of the molecular dynamics of protei...

Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry. Frank H. Laukien, chairman, president and CEO of Bruker Corporation, stated: “Bruker is delighted to add Jack to our board of directors. His broad and deep diag...
Back to Newsroom